title: Inflammatory bowel disease in pregnancy: management strategy based on best evidence and European guidelines.
authors.affiliation: MBBS4, King's College London, London.
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Kubota-Sjogren
authors.affiliation: Guy's and St Thomas' Hospital Foundation Trust, King's Health Partnership, London.
authors.forename: Kate
authors.initials: K
authors.lastname: Harding
authors.affiliation: Guy's and St Thomas' NHS Trust, London.
authors.forename: Peter
authors.initials: P
authors.lastname: Irving
authors.affiliation: Women's Health Academic Centre, Consultant Obstetric Physician, Guy's and St Thomas' NHS Trust and ICHCT, London.
authors.forename: Catherine
authors.initials: C
authors.lastname: Nelson-Piercy
mesh_terms: D001942:Breast Feeding; D000075202:Contraindications; D036861:Delivery, Obstetric; D005260:Female; D005493:Folic Acid Antagonists; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D039382:Maternal Nutritional Physiological Phenomena; D008727:Methotrexate; D009173:Mycophenolic Acid / Q000031:analogs & derivatives; D017410:Practice Guidelines as Topic; D016742:Preconception Care; D011247:Pregnancy; D011248:Pregnancy Complications; D011320:Primary Health Care
chemical_list: D005493:Folic Acid Antagonists; D009173:Mycophenolic Acid; D008727:Methotrexate